Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: Four cases and review

Clinical Microbiology and Infection

Volumn 5, Issue 11, 1999, Pages 672-686

  Gosbell, Iain B ^a   Morris, Michelle L ^b   Gallo, John H ^a   Weeks, Kerry A ^a   Neville, Stephen A ^a   Rogers, Anthony H ^b   Andrews, Ross H ^b   Ellis, David H ^c  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b Department of Dentistry ^*

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Antifungal agents; Disease outbreaks; Hyphomycetes; Immunocompromised host; Leukemia; Microbial sensitivity tests; Mycologic typing techniques; Opportunistic infections; Scedosporium prolificans

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CYTOTOXIC AGENT; ITRACONAZOLE;

ABSCESS; ADULT; AGED; AIR SAMPLING; ARTICLE; AUTOPSY; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; ELECTROPHORESIS; FEMALE; HUMAN; HYPHOMYCETES; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHOMA; MALE; MEDICAL LITERATURE; MINIMUM INHIBITORY CONCENTRATION; MYCELIUM; MYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SOIL; STRAIN DIFFERENCE; TISSUE NECROSIS;

HYPHOMYCETES; SCEDOSPORIUM PROLIFICANS;

EID: 0032750164     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00513.x     Document Type: Article

References (52)

1. Malloch D, Salkin IF. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon 1984; 21: 247-55.
2. Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia 1989; 106: 13-22.
3. Salkin IF, McGinnis MR, Dykstra MJ, et al. Scedosporium inflatum, an emerging pathogen. J Clin Microbiol 1988; 26: 498-503.
4. Hopwood V, Evans EG, Matthews J, et al. Scedosporium prolificans, a multi-resistant fungus, from a UK AIDS patient. J Infect 1995; 30: 153-5.
5. Chikhani L, Dupont B, Guilbert F, et al. Une sinusite maxillaire fongique exceptionnelle d'origine dentaire a Scedosporium prolificans. Rev Stomatol Chirurg Maxillofaciale 1995; 96: 66-9.
6. del Palacio A, Cuetara MS, Lumbreras C, et al. Colonization transitoria por Scedosporium prolificans (inflatum) en enferma sometida a trasplante hepatico. Enferm Infecc Microbiol Clin 1994; 12: 523-4.
7. Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027-33.
8. Wilson CM, O'Rourke EJ, McGinnis MR, et al. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990; 161: 102-7.
9. Toy EC, Rinaldi MG, Savitch CB, et al. Endocarditis and hip arthritis associated with Scedosporium inflatum. South Med J 1990; 83: 957-60.
10. Spielberger RT, Tegtmeier BR, O'Donnell MR, et al. Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States. Clin Infect Dis 1995; 21: 1067.
11. Alvarez M, Ponga BL, Rayon C, et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33: 3290-5.
12. Tapia M, Richard C, Baro J, et al. Scedosporium inflatum infection in immunocompromised haematological patients. Br J Haematol 1994; 87: 212-14.
13. Farag SS, Firkin FC, Andrew JH, et al. Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient. J Infect 1992; 25: 201-4.
14. Wise KA, Speed BR, Ellis DH, et al. Two fatal infections in immunocompromised patients caused by Scedosporium inflatum. Pathology 1993; 25 187-9.
15. Salesa R, Burgos A, Ondiviela R, et al. Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation. Scand J Infect Dis 1993; 25: 389-93.
16. Marin J, Sanz MA, Sanz GF, et al. Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis 1991; 10: 759-61.
17. Bouza E, Munoz P, Vega L, et al. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996; 23: 192-3.
18. Pickles RW, Pacey DE, Muir DB, et al. Experience with infection by Scedosporium prolificans including apparent cure with fluconazole therapy. J Infect 1996; 33: 193-7.
19. Nenoff P, Gutz U, Tintelnot K, et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996; 39: 461-5.
20. Rabodonirina M, Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994; 19: 138-42.
21. Madrigal V, Alonso J, Bureo E, et al. Fatal meningoencephalitis caused by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia. Eur J Clin Microbiol Infect Dis 1995; 14: 601-3.
22. Guarro J, Gaztelurrutia L, Marin J, et al. Scedosporium inflatum, un nuevo hongo patogeno. A proposito de dos casos con desenlace fatal. Enferm Infecc Microbiol Clin 1991; 9: 557-60.
23. Selander RK, Caugant DA, Ochman H, et al. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986; 51: 873-84.
24. Richardson BJ, Baverstock PR, Adams M. Allozyme electrophoresis: a handbook for animal systematics and population studies. Sydney: Academic Press, 1986.
25. Kennedy MJ, Sigler L. Aspergillus, Fusarium, and other opportunistic moniliaceous fungi. In Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1995: 765-90.
26. Ellis DH. Pseudallescheriasis and scedosporium infection. In Ellis DH, ed. Clinical mycology, the human opportunistic mycoses. New York: Pfizer Inc, 1994: 79-83.
27. Shadomy S. Miscellaneous fungi. In Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. Philadelphia: WB Saunders Company, 1992: 1946-51.
28. Bennett JE. Miscellaneous fungi, and prototheca. In Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. New York: Churchill Livingstone Inc., 1995: 2389-93.
29. McGinnis MR, Salkin IR, Schell WA, et al. Dematiaceous fungi. In: Balows A, Hausler WJ, Herrmann KL, et al, eds. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1991: 644-58.
30. Ellis D, Davis S, Alexia H, et al. Scedosporium prolificans. In Ellis D, Davis S, Alexia H, et al, eds. Descriptions of medical QAP fungi. Adelaide: Mycology Unit, Adelaide Children's Hospital, 1992: 103.
31. Rippon JW. Pseudallescheriasis. In: Medical mycology: the pathogenic fungi and the pathogenic actinomycete. Philadelphia, PA: WB Saunders and Co., 1988: 651-80.
32. Warnock DW, Johnson EM. Clinical manifestations and management of hyalophomycosis, phaeohyphomycosis and other uncommon forms of fungal infection in the compromised patient. In Warnock DW, Richardson MD, eds. Fungal infection in the compromised patient. Chichester: Wiley & Sons, 1991: 247-310.
33. Schell WA, Pasarell L, Salkin IF, McGinnis MR. Bipolaris, Exophiala, Scedosporium, Sporothrix, and other dematiaceous fungi. In Murray PR, Baron EJ, Pfaller MA, et al. Manual of clinical microbiology. Washington DC: American Society tor Microbiology, 1995: 825-46.
34. Figueras MJ, Cano JF, Guarro J. Ultrastructural alterations produced by sertaconazole on several opportunistic pathogenic fungi. J Med Vet Mycol 1995; 33: 395-401.
35. Sullivan LJ, Snibson G, Joseph C, et al. Scedosporium prolificans sclerokeratitis. Aust NZ J Ophthalmol 1994; 22: 207-9.
36. Nielsen K, Lang H, Shum AC, et al. Disseminated Scedosporium prolificans infection in an immunocompromised adolescent. Pediatr Infect Dis J 1993; 12: 882-4.
37. Moriarty AP, Crawford GJ, McAllister IL, et al. Fungal corneoscleritis complicating beta-irradiation-induced scleral necrosis following pterygium excision. Eye 1993; 7: 525-8.
38. Moriarty AP, Crawford GJ, McAllister IL, et al. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol 1993; 111: 947-51.
39. Sparrow SA, Hallam LA, Wild BE, et al. Scedosporium inflatum: first case report of disseminated infection and review of the literature. Pediatr Hematol Oncol 1992; 9: 293-5.
40. Malekzadeh M, Overturf GD, Auerbach SB, et al. Chronic, recurrent osteomyelitis caused by Scedosporium inflatum. Pediatr Infect Dis J 1990; 9: 357-9.
41. Garland J, Stool E, Gathe J Jr, et al. Disseminated Scedosporium inflatum infection in a patient with AIDS [abstract 7196], In: VIII International Conference on AIDS, Amsterdam. London: International Aids Society, 1992; 81.
42. Gillum PS, Gurswami A, Taira JW. Localized cutaneous infection by Scedosporium prolificans (inflatum). Int J Dermatol 1997; 36: 297-9.
43. Berenguer J, Rodriguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine 1997; 76: 256-65.
44. Kumar B, Crawford GJ, Morlet GC. Scedosporium prolificans corneoscleritis: a successful outcome. Aust NZ J Ophthalmol 1997; 25: 169-71.
45. Feltkamp MC, Kersten MJ, van der Lelie J, et al. Fatal Scedosporium prolificans infection in a leukemic patient. Eur J Clin Microbiol Infect Dis 1997; 16: 460-4.
46. Chikhani L, Dupont B, Guilbert F, et al. Une sinusite maxillaire fongique exceptionnelle d'origine dentaire a Scedosporium prolificans. Rev Stomatol Chirurg Maxillofaciale 1995; 96: 66-9.
47. Nenoff P, Horn LC, Schwenke H, et al. Invasive Schimmelpilzinfektionen am Universitatsklinikum Leipzig im Zeitraum 1992-1994. Mycoses 1996; 39 (suppl 1): 107-12.
48. Cano J, Guarro J, Mayayo E, et al. Experimental infection with Scedosporium inflatum. J Med Vet Mycol 1992; 30: 413-20.
49. Zaidi AK, Mirrett S, McDonald JC, et al. Controlled comparison of bioMérieux VITAL and BACTEC NR-660 systems for detection of bacteremia and fungemia in pediatric patients. J Clin Microbiol 1997; 35: 2007-12.
50. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol 1989; 5: 131-42.
51. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother 1997; 41: 841-3.
52. Ruiz-Diez B, Martm-Diez F, Rodriguez-Tudela JL, et al. Use of random amplification of polymorphic DNA (RAPD) and PCR-fingerprinting for genotyping a Scedosporium prolificans (inflatum) outbreak in four leukemic patients. Curr Microbiol 1997; 35: 186-90.